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Introduction
The assessment of a child with acute join pain and swelling
needs to differentiate between various conditions. JIA is
the most common form of childhood arthritis and one
of the most common chronic childhood illnesses. JIA sub-
types demonstrate unique clinical presentations and clini-
cal courses. The pain and functional disability associated
with JIA cause significant burden for patients and their
families, affecting on health-related quality of life and well-
being. Therefore, JIA should be recognised and treatment
started as soon as possible. Early diagnosis is a determinant
step in the management of these patients to prevent the
effects of an illness.
Objectives
To investigate clinical and laboratory manifestations of
acute early arthritis and determine early predictors of JIA
Methods
Early arthritis programme is performed in the Vilnius
University Children Hospital, Pediatric Rheumatology
Department. Patients from whole Lithuania with acute
arthritis (disease’s duration from 1 weeks to 3 months)
symptoms are included. Special questionnaire, CHAQ,
general status, active joint count, systemic manifestations,
immunological parameters (ANA, HLA B27, RF), acute
phase reactants, serology (Yersinia, Salmonella, ASL) are
assessed at the first visit and after 6, 12, 24 months of
follow up.
Results
106 patients (from 2010-2013 years) with acute arthritis
symptoms were enrolled in the study, 60 girls and 46
boys. Range of age was from 1 to 17 years (mean 8, 32
+ 5,053 years) with the median disease period from the
first symptoms 6,2 + 3,45 weeks. Monoarthritis was
observed in 55, 9% patients, 29% had oligoarthritis-onset
and 15, 1% polyarthritis-onset disease course. Morning
stiffness was absent in 25% of children. 25 patients (23,
4%) were ANA positive at high titre (19/25 - 1:200).
ANA were most prevalent in polyarthritis subgroup (27,
5%) and predominantly with a diffuse granular pattern.
Also ANA was more common for boys more then
9 years. HLA B27 positive patients were 23, 4% (28%
had both ANA and HLA B27, equally in subgroups).
The diagnosis was determined according to the Interna-
tional League of Associations for Rheumatology (ILAR)
1997 classification during follow up period after
6 month from disease onset. Juvenile idiopathic arthri-
tis was the most frequent diagnosis (50%), undifferen-
tiated arthritis - 25, 5%, reactive cause of arthritis - 20,
75%. Systemic lupus erythematosus, leukemia, sarcoma
were single cases. At the time of first symptoms pain
severity was similar among all types of arthritis. Chil-
dren with JIA reporter less pain and greater wellbeing
than other children with others diseases, however
rated more disability of quality of life (CHAQ median 0,
785 + 0, 75).
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Conclusion
In our cohort clinical and routine laboratory (also ANA,
HLA B27) parameters couldn’t early predict particular
JIA form. It may be relationship between acute arthritis
symptoms and quality of life. Also ANA and HLA B27
were not so frequent and predominated more in older
boys. The study is ongoing and further more sensitive
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